Evidence-based medicine and COVID-19 : what to believe and when to change
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ..
The COVID-19 pandemic has led to a surge of information being presented to clinicians regarding this novel and deadly disease. There is a clear urgency to collate, review, appraise and act on this information if we are to do the best for clinicians and patients. However, the speed of the pandemic is a threat to traditional models of knowledge translation and practice change. In this concepts paper, we argue that clinicians need to be agile in their thinking and practice in order to find the right time to change. Adoption of new methods should be based on clinical judgement, the weight of evidence and the balance of probabilities that any new technique, test or treatment might work. The pandemic requires all of us to reach a new level of evidence-based medicine characterised by scepticism, thoughtfulness, responsiveness and clinically agility in practice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Emergency medicine journal : EMJ - 37(2020), 9 vom: 10. Sept., Seite 572-575 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Carley, Simon [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Editorial |
|---|
| Anmerkungen: |
Date Completed 11.09.2020 Date Revised 04.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/emermed-2020-210098 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312279191 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312279191 | ||
| 003 | DE-627 | ||
| 005 | 20231225144053.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/emermed-2020-210098 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1040.xml |
| 035 | |a (DE-627)NLM312279191 | ||
| 035 | |a (NLM)32651176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Carley, Simon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evidence-based medicine and COVID-19 |b what to believe and when to change |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.09.2020 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a The COVID-19 pandemic has led to a surge of information being presented to clinicians regarding this novel and deadly disease. There is a clear urgency to collate, review, appraise and act on this information if we are to do the best for clinicians and patients. However, the speed of the pandemic is a threat to traditional models of knowledge translation and practice change. In this concepts paper, we argue that clinicians need to be agile in their thinking and practice in order to find the right time to change. Adoption of new methods should be based on clinical judgement, the weight of evidence and the balance of probabilities that any new technique, test or treatment might work. The pandemic requires all of us to reach a new level of evidence-based medicine characterised by scepticism, thoughtfulness, responsiveness and clinically agility in practice | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a education | |
| 650 | 4 | |a education, teaching | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a performance improvement | |
| 650 | 4 | |a quality | |
| 700 | 1 | |a Horner, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Body, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Mackway-Jones, Kevin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Emergency medicine journal : EMJ |d 2001 |g 37(2020), 9 vom: 10. Sept., Seite 572-575 |w (DE-627)NLM112090672 |x 1472-0213 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2020 |g number:9 |g day:10 |g month:09 |g pages:572-575 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/emermed-2020-210098 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2020 |e 9 |b 10 |c 09 |h 572-575 | ||